Priory’s Harley Street Wellbeing Centre in the UK offers innovative drug-free approach to depression
- Benefits can be seen in as little as 2 weeks
- Transcranial Magnetic Stimulation is non-invasive
- Patients from abroad can access treatment lasting 2 weeks, avoiding lengthy stays in London
- The Wellbeing Centre has successfully treated patients for depression using TMS
- Drugs for depression don’t suit everyone, says Centre’s medical director
- It is also a safe treatment for pregnant women
- Patients can resume work, or can drive, straight after a treatment session
Depression is the leading cause of ill-health and disability worldwide. It causes a great deal of suffering, and can be fatal. According to latest estimates from the World Health Organisation, more than 300 million people are living with it.
Psychotherapy and medication are the ‘first line’ treatments, and in England alone, the number of prescriptions for anti-depressants has almost doubled in the past decade. Data from NHS Digital, the Health and Social Care Information Centre for England’s state-funded National Health Service, shows that 70.9 million prescriptions for anti-depressants were given out in 2018, compared with 36 million in 2008.
But while medication is beneficial for many, it is not a catch-all.
“Medication is not effective in up to 50% of patients, not everyone wants to take pills, and some people have unacceptable adverse effects,” says Dr Leon Rozewicz, the medical director of Priory’s Wellbeing Centre in Harley Street, the renowned medical area in central London.
So Priory’s Wellbeing Centre there offers an effective, evidence-based, alternative biological treatment that has been approved by the National Institute of Clinical and Health Care Excellence (NICE). Improvement can be seen by some patients in as little as two weeks.
Dr Rozewicz says. “If the first anti-depressant medication you try does not work, the next one is less likely to work. Once you have tried three medications for depression, the probability that the fourth will work is about 15%.
“Repetitive transcranial magnetic stimulation (rTMS) is a form of non-invasive brain stimulation that provides an effective non-pharmaceutical treatment.
“Rapidly alternating magnetic pulses are generated over the scalp, which stimulate specific brain regions involved in depression. The aim is to increase the connectivity of brain cells. The method may be used alongside medication or without medication.
“The process requires no anaesthetics or sedatives. It causes no sedation and no memory loss.”
A video of the treatment is available to watch here, and includes an interview with Dr Rozewicz: https://www.youtube.com/watch?v=Yo0xGoOCqAw
rTMS has been tested in several hundred clinical studies worldwide and evidence shows a high and positive response rate. NICE assessed rTMS by looking at the outcomes of seven particular studies which involved more than 6,000 patients. They concluded that rTMS was both safe and effective. In 2007, NICE approved it as a treatment of depression. The U.S. Food and Drug Administration has also approved rTMS.
“Patients who have failed to achieve an adequate response from anti-depressants, or who are unable to tolerate medications, should definitely consider rTMS,” says Dr Rozewicz
“If you come in with a depressive illness and you get medication, the response rate to that medication is about 40%-50%. In studies of anti-depressant effectiveness, 20-30% of people will just drop out. In rTMS studies, less than 5% drop out. People tolerate it very well. It’s also more effective than anti-depressants in what we call ‘treatment-resistant’ depression. The other part of the story is that it doesn’t really have adverse effects. You get some minor discomfort during treatment and you may have a mild headache for one to two hours afterwards.
“Unlike ECT (electroconvulsive therapy), no current passes through your head, there is no electric shock. It does not require an anaesthetic, you can resume all usual activities (including work and driving) immediately at the end of a treatment session.”
Typically, patients have treatment five days per week for four to six consecutive weeks. Each session lasts 19 minutes. Dr Rozewicz says: “We are also able to offer a rapid treatment protocol (theta burst). Patients have two to three sessions per day, lasting three minutes each, treatment can be completed in two weeks. This rapid treatment protocol may suit patients from abroad.”
The Priory Wellbeing Centre has invested £100,000 to integrate the state-of-the-art rTMS equipment into its Harley Street location. A specialist team of staff co-ordinate and manages the rTMS programme, and support patients closely through the process.
The Priory Group is the world-famous independent provider of mental healthcare with hospitals, rehabilitation centres and Wellbeing Centres across the UK, and a Wellbeing Centre in Dubai.
Priory Hospitals and Wellbeing Centres are fully regulated by the Care Quality Commission (CQC), and provide therapy and treatments for conditions including depression, anxiety, stress, anger management, eating disorders, addictions and relationship and bereavement counselling.
Priory’s Wellbeing Centres
Across the UK, Priory’s Wellbeing Centres bring swift access to patients in need of mental healthcare. Priory is an approved provider for all the UK’s leading private medical insurers. Most outpatient therapy services are covered as standard by the majority of insurers, meaning people may be able to access treatment at no additional cost. Priory also provides self-pay options for individuals and families, along with arrangements for businesses looking to support their employees. Too often people do not realise their health insurance will cover a mental health assessment and treatment.
Priory Wellbeing Centres are also located in Birmingham, Southampton, Canterbury, Aberdeen, Edinburgh, Greater Manchester, London (Fenchurch St) and Oxford. The Priory Group opened its first overseas Wellbeing Centre in Dubai in 2016.
About Priory Group
The Priory Group is the leading provider of behavioural care in the UK, caring for around 30,000 people a year for conditions including depression, anxiety, drug and alcohol addiction, eating disorders and self-harming. The Group is organised into four divisions – healthcare, education and children’s services, adult care and the Middle East. The Priory Group is owned by NASDAQ-listed Acadia Healthcare, which is recognised as a global leader in behavioural health.